These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

800 related items for PubMed ID: 26647384

  • 1. TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.
    Rafehi S, Ramos Valdes Y, Bertrand M, McGee J, Préfontaine M, Sugimoto A, DiMattia GE, Shepherd TG.
    Endocr Relat Cancer; 2016 Mar; 23(3):147-59. PubMed ID: 26647384
    [Abstract] [Full Text] [Related]

  • 2. Notch and TGFβ form a positive regulatory loop and regulate EMT in epithelial ovarian cancer cells.
    Zhou J, Jain S, Azad AK, Xu X, Yu HC, Xu Z, Godbout R, Fu Y.
    Cell Signal; 2016 Aug; 28(8):838-49. PubMed ID: 27075926
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.
    Du J, Sun B, Zhao X, Gu Q, Dong X, Mo J, Sun T, Wang J, Sun R, Liu Y.
    Gynecol Oncol; 2014 Jun; 133(3):575-83. PubMed ID: 24589413
    [Abstract] [Full Text] [Related]

  • 4. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
    Karicheva O, Rodriguez-Vargas JM, Wadier N, Martin-Hernandez K, Vauchelles R, Magroun N, Tissier A, Schreiber V, Dantzer F.
    Oncotarget; 2016 Sep 27; 7(39):64109-64123. PubMed ID: 27579892
    [Abstract] [Full Text] [Related]

  • 5. BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.
    Peart TM, Correa RJ, Valdes YR, Dimattia GE, Shepherd TG.
    Clin Exp Metastasis; 2012 Apr 27; 29(4):293-313. PubMed ID: 22249415
    [Abstract] [Full Text] [Related]

  • 6. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R, Suzuki Y, Furutani Y, Takahashi K, Yoshimatsu Y, Podyma-Inoue KA, Watabe T, Sato Y.
    Cancer Sci; 2017 Mar 27; 108(3):419-426. PubMed ID: 28064471
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Conditioned media from human ovarian cancer endothelial progenitor cells induces ovarian cancer cell migration by activating epithelial-to-mesenchymal transition.
    Teng L, Peng S, Guo H, Liang H, Xu Z, Su Y, Gao L.
    Cancer Gene Ther; 2015 Nov 27; 22(11):518-23. PubMed ID: 26494557
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A novel network integrating a miRNA-203/SNAI1 feedback loop which regulates epithelial to mesenchymal transition.
    Moes M, Le Béchec A, Crespo I, Laurini C, Halavatyi A, Vetter G, Del Sol A, Friederich E.
    PLoS One; 2012 Nov 27; 7(4):e35440. PubMed ID: 22514743
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A Systematic Analysis of Negative Growth Control Implicates the DREAM Complex in Cancer Cell Dormancy.
    MacDonald J, Ramos-Valdes Y, Perampalam P, Litovchick L, DiMattia GE, Dick FA.
    Mol Cancer Res; 2017 Apr 27; 15(4):371-381. PubMed ID: 28031411
    [Abstract] [Full Text] [Related]

  • 16. Downregulation of miR-153 contributes to epithelial-mesenchymal transition and tumor metastasis in human epithelial cancer.
    Xu Q, Sun Q, Zhang J, Yu J, Chen W, Zhang Z.
    Carcinogenesis; 2013 Mar 27; 34(3):539-49. PubMed ID: 23188671
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. TGFβ and EGF synergistically induce a more invasive phenotype of epithelial ovarian cancer cells.
    Xu Z, Jiang Y, Steed H, Davidge S, Fu Y.
    Biochem Biophys Res Commun; 2010 Oct 22; 401(3):376-81. PubMed ID: 20854793
    [Abstract] [Full Text] [Related]

  • 20. Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.
    Latifi A, Abubaker K, Castrechini N, Ward AC, Liongue C, Dobill F, Kumar J, Thompson EW, Quinn MA, Findlay JK, Ahmed N.
    J Cell Biochem; 2011 Oct 22; 112(10):2850-64. PubMed ID: 21618587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.